ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION

Size: px
Start display at page:

Download "ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION"

Transcription

1 ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION 1. The Brazilian Archives of Cardiology (Arq Bras Cardiol) is a monthly publication of the Brazilian Society of Cardiology, indexed in the Cumulated Index Medicus of the National Library of Medicine and the MEDLINE, EMBASE, LILACS, Scopus and SciELO databases, with PubMed (United States National Library of Medicine) citation in English and Portuguese. 2. By submitting a manuscript, the authors must certify that the work has not been previously published or is being considered for publication elsewhere. All scientific contributions are reviewed by the Editor-in-Chief, the Editorial Advisor, Associate Editors and the Members of the Editorial Board. Only articles that strictly comply with the specified guidelines will be sent to reviewers. Manuscripts will also undergo statistical review, as necessary. Acceptance is contingent upon originality, significance and scientific contribution to knowledge in the field. 3. Sections 3.1. Editorial: All Editorials are written by invitation. Spontaneously submitted editorials will not be accepted Letter to the Editor: correspondence of scientific content related to articles published in the previous two months will be evaluated for publication. The authors of the quoted original article will be invited to respond Original Articles: the journal accepts all kinds of original research in the cardiovascular field, including research in humans and experimental research Review Articles: editors invite authors to write most reviews. However, high-quality review articles, by authors or groups with a history of publications in the field are welcome. Only articles written by authors with a broad academic curriculum or publication experience will be accepted, as verified by the Lattes system (CNPQ), Pubmed or SCIELO. Occasionally, spontaneously submitted reviews may be reclassified as "Clinical Update" and published on the journal's web site (see below) Brief Communication: original experiences, of which relevance to the theme justifies the presentation of initial data from small series or partial data from clinical trials, will be accepted for review.

2 3.6. Anatomo-Clinical Correlation: presentation of a clinical case and discussion of topics of interest related to clinical, laboratory and anatomopathological content Clinical-Radiographic Correlation: presentation of a congenital heart disease case, emphasizing the importance of radiographic and/or clinical elements for subsequent correlation with other tests, which will confirm the diagnosis, thus justifying the conduct Clinical Update: this section aims to focus on themes of clinical interest, but with more limited impact potential. High-quality articles, performed by authors or groups with a history of publications in the area will be accepted for review Case Report: cases that include original descriptions of clinical observations or that represent originality of a diagnosis or treatment, or depict uncommon situations in clinical practice, and deserve greater understanding and attention from cardiologists will be accepted for review Cardiovascular Image: clinical or basic research images, or of complementary examinations that depict interesting aspects of imaging methods, clarify cardiovascular disease mechanisms and highlight relevant points of physiopathology, diagnosis, or treatment will be considered for publication Point of View: it presents the authors position or opinion on a specific scientific topic. This position or opinion should be adequately substantiated in literature or on their personal experience, aspects that will be the basis for the opinion to be given. 4. Submission process: Manuscripts should be submitted via internet and system, available at: 5. All articles must be accompanied by a cover letter to the editor, indicating the section to which the article is being submitted (see list above) and author s statement that all coauthors are in agreement with the content of the article, declaring the existence or not of *conflicts of interest and lack of associated ethical problems. 6. All manuscripts are considered for publication as soon as possible; however, works that require special review for expedited review process ("fast-track") should be indicated in the submission letter to the editor. 7. Text and tables should be edited in Word and figures and illustrations should be attached in separate files in the appropriate area of the system. All figures should be in.jpg format with a minimum resolution of 300 DPI. The Standards for Formatting Tables, Figures and Charts are found in

3 Conflict of interest: when there is some association between authors and any public or private entity that can originate a conflict of interest, this possibility should be notified and informed at the end of the article. Send a Declaration of Potential Conflict of Interest to revista@cardiol.br and include the manuscript number in the subject line. Access: 9. Author s contribution form: the corresponding author must complete, sign and send by (to revista@cardiol.br - include manuscript number in the subject line) the forms, explaining the contributions of all authors, which will be reported at the end of the article. Access: Copyright: the authors of accepted articles must send a statement of copyright transfer to the Archives, before the publication, signed by all coauthors (fill out the form at and send it to revista@cardiol.br, including the manuscript number in the subject line). 11. Ethics The authors must disclose, in the manuscript and/or in the article file, whether the study was approved by the Research Ethics Committee of the institution in compliance with the Declaration of Helsinki In experimental studies involving animals, the standards set out in the Guide for the Care and Use of Laboratory Animals (Institute for Laboratory Animal Research, National Academy of Sciences, Washington D.C., 2011) and Ethical Principles on Animal Experimentation of the National Animal Control Council (CONCEA) must be respected In experimental studies involving human subjects, authors must indicate whether the procedures followed the ethical standards of the committee responsible for human experimentation (institutional and national) and the Declaration of Helsinki of 1975, revised in If there is any doubt regarding the study performance in accordance with the Helsinki Declaration, the authors must explain the reasons for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. Studies in human subjects must be in accordance with the ethical standards and contain the participants free and informed consent according to Resolution 196/96 of the National Board of Health, Ministry of Health (Brazil), which

4 deals with the Code of Ethics for Research in Human Subjects and, for authors outside Brazil, they must comply with Committee on Publication Ethics (COPE). 12. Clinical trials The International Committee of Medical Journal Editors (ICMJE) and the World Health Organization (WHO) believe that it is important to promote a comprehensive and publicly available clinical trial database. The ICMJE defines a clinical trial as any research project that prospectively assigns human beings to intervention or simultaneous comparison or control groups to study the cause and effect association between a medical intervention and a health-related outcome. Medical interventions include drugs, surgical procedures, devices, behavioral treatments, changes in the care process and others The study registration number should be published at the end of the summary. Any registration that meets the ICMJE requirements will be accepted; e.g., A complete list of all registries of clinical trials can be found at: Clinical trials must follow the CONSORT STATEMENT rules in its presentation. Access Bibliographic references: the Archives adopt the Vancouver style - Uniform Requirements for Manuscripts Submitted to Biomedical Journals ( 14. Language: Articles must be written in Portuguese (following current orthographic rules) and / or English For articles that do not have an English version or when the latter is considered inadequate by the Editorial Board, the journal will provide translation at no cost to the author (s) When there is an English version available, it should be sent to expedite publication The English and Portuguese versions of the manuscripts will be made available in full on SBC ( and SciELO websites ( remaining accessible to the international community.

5 15. Peer review: all manuscripts submitted to ABC will undergo an initial evaluation by the editors, who will decide whether or not the manuscript will be submitted to peer-review; all reviewers are researchers that have regularly published articles in indexed journals and highly qualified cardiologists (ABC Body of Reviewers: Authors may designate up to five members of the Board of Reviewers for analysis of the submitted manuscript, as they may designate up to five reviewers not to participate in the process Reviewers will make general comments on the manuscript and decide whether it should be published, corrected according to recommendations, or rejected The Editors, after considering the reviewers comments, will make the final decision. In case of discrepancies between reviewers, a new review may be requested for a better decision Modification suggestions made by reviewers will be forwarded to the main author. After the manuscript has been modified to fit the new requirements, it will be forwarded to the reviewers for verification In exceptional cases, when the subject of the manuscript so requires, the Editor may request the assistance of a professional not listed in the Body of Reviewers The authors have thirty days to make the modifications requested by reviewers and resubmit the article. Failure to comply with this deadline will result in the removal of the article from the reviewing process After accepting the review, reviewers must issue their decision within 30 days Decisions will be communicated by message through the System of Article Submission and by The decisions of the editors will not be discussed in person or by phone. Responses should be submitted in writing to the journal.

6 Number of words: electronic word count should include the title page, summary, text, references and figure/table legends. Original Article Editorial Review Article Clinical Update Case Report Brief Communication Point of View Letter to Editor Image Correlations Maximum number of authors Title (characters including spaces) Running Title (characters including spaces) Summary (maximum n. of words) Maximum n. of words (including references) Maximum n. of references Maximum n. of tables + figs + video

7 Statistical guidelines The appropriate use of statistical methods, as well as their correct description, is of utmost importance to have your article published at the Brazilian Archives of Cardiology (Arquivos Brasileiros de Cardiologia). Thus, the following general guidelines are presented to the authors on the information that must be provided in the article regarding the statistical analysis (for details, please read the statistical guidelines of the European Heart Journal). 1) About the sample: Provide details on both the population of interest and the procedures used to define the study sample. 2) In the Methods section, create a subsection exclusively dedicated to the description of the statistical analysis performed in the study, including: Presentation of continuous and/ or categorical variables: for continuous variables with normal distribution, mean and standard deviation should be used, whereas median and interquartile ranges should be used with those with non-normal distribution. As for categorical variables, they must be depicted as absolute numbers and percentages, with the respective confidence intervals; Description of the statistical methods used. When using more complex statistical methods, a literature reference must be provided for such methods; As a rule, statistical tests should always be two-sided, instead of one-sided; Level of statistical significance used; and Specification of the software used in the statistical analysis and its respective version. 3) Regarding the presentation of results after the statistical analysis: The main results should always be described with their respective confidence intervals; Do not repeat in the manuscript body data that have already been depicted in tables and figures; Rather than having very large tables, use charts alternatively to facilitate reading and understanding of the content; At the tables, even if the p value is non-significant, provide its respective value instead of "NS" (e.g., p = 0.29 instead of NS).

8 16. Articles must include the following order: Title page Text Acknowledgements Figure legends Tables (including legends for abbreviations) References First page: it must contain the full title of the article, in a succinct and descriptive manner, in Portuguese and English languages, as well as a short title (up to 50 characters including spaces) to be used in the article page headers; Three to five keywords must be included, as well as their respective translation. Key words can be consulted at which contains terms in Portuguese, Spanish and English or /mesh for terms in English only; Second page: Summary (250 words): The summary should be structured into five sections when it is an Original Article, avoiding abbreviations and considering the maximum number of words. In the case of Review Articles and Brief Communications, the summary is not structured, considering the maximum word limit. No references must be mentioned in the Summary: Background (rationale for the study);

9 Objectives; Methods (brief description of the used methodology); Results (only the main and most significant ones); Conclusions (succinct sentence(s) with data interpretation). Obs.: Case Reports do not need a Summary Original Article text: should be divided into: Introduction, Methods, Results, Discussion and Conclusions Introduction: It must not have more than 350 words Write a description of the study background and rationale, justifying it based on the literature Methods: describe in details how subjects were selected from observational or experimental research (patients or laboratory animals, including the control group, if any), including age and gender Ethnicity must be mentioned when possible and clearly stated when relevant to the assessed topic Identify the equipment and reagents (including manufacturer, model and country of manufacture where appropriate) and give details of the procedures and techniques used in order to allow other researchers to reproduce your data Justify the methods used and evaluate possible limitations Describe all drugs and medications used, doses and routes of administration Describe the protocol used (interventions, outcomes, methods of allocation, blinding, and statistical analysis).

10 In case of studies in human subjects indicate that the study was approved by a Research Ethics Committee and that patients signed the free and informed consent Results: must be clearly presented, subdivided into sections, when possible, and supported by a moderate number of graphs, tables and figures. Avoid redundancy when presenting data, as in both the text and tables Discussion: it is directly related to the proposed topic, when analyzed in light of the literature, emphasizing new and important aspects of the study, its implications and limitations. The last paragraph should express the study findings or, if appropriate, recommendations and clinical implications Conclusions At the end of the Conclusions section, indicate the study sources of funding. 17. Acknowledgements must come after the text. In this section, authors can thank all the sources of support for the research project, as well as individual contributions Each person mentioned in the acknowledgments section should send a letter authorizing the use of his/her name, as it can imply endorsement of data and conclusions Written consent from members of the work team or from external collaborators is not necessary, as long as the role of each of them is described in the acknowledgments section. 18. References: the Archives use the Vancouver style References must be cited numerically in order of appearance in the text and presented in superscript If more than two references are cited in sequence, only the first and last should be types, separated by a dash (Example 5-8) For alternating citations, all references should be typed, separated by a comma (Example: 12, 19, 23). Abbreviations should be defined when they first appear in the text.

11 18.4. References must be aligned to the left Personal communications and unpublished data must not be included in the reference list, but mentioned in the text and in a footnote on the page where it has been mentioned Cite all study authors if there are six authors or fewer, or only the first six followed by et al. if there are more than six authors Journal abbreviations must comply with Index Medicus / Medline - posted in List of Journals Indexed in Index Medicus or through the site Only indexed journal citations will be accepted. The cited books should have an ISBN (International Standard Book Number) registration number Summaries presented at conferences will be accepted up to two years after submission and must contain the term "congress abstract" or "abstract" in the reference. 19. Recovery policy: the editors encourage the citation of articles published in the Archives. 20. Tables must be numbered in order of appearance and used as necessary for a better understanding of the study. Tables should not contain data previously reported in the text. Indicate footnote markers in the following order: *,,,, //,, #, **,, etc. The Manual for the Formatting of Tables, Figures and Graphs for Submission of Articles to ABC Journal can be found at: Figures: submitted figures must have good resolution to be assessed by the reviewers. Figure legends should be double-spaced, and be numbered and placed before the References. The abbreviations used should be explained in the legends. The Manual for the Formatting of Tables, Figures and Graphs for Submission of Articles to ABC Journal can be found at:

12 22. Images and videos: accepted articles containing medical examinations (e.g., echocardiograms and coronary angiography) must be submitted through the article submission system as motion pictures in MP4 format with codec system h:264, with a maximum of 20 megabytes, to be made available at the website: and tablet-version electronic journals. 23. The authors are not subjected to submission fee of articles and evaluation.

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION 1 ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION 1. The Brazilian Archives of Cardiology (Arq Bras Cardiol) is a monthly publication of the Brazilian

More information

Manuscript Submission Guidelines: Health Services Research and Managerial Epidemiology

Manuscript Submission Guidelines: Health Services Research and Managerial Epidemiology Manuscript Submission Guidelines: Health Services Research and Managerial Epidemiology 1. Open Access 2. Peer Review Policy 3. Article Types 4. Publication Fees 5. Authorship 6. How to submit your manuscript

More information

Kathy O Kane Kreutzer, M.Ed., Office of Faculty Affairs, School of Medicine March, 2017

Kathy O Kane Kreutzer, M.Ed., Office of Faculty Affairs, School of Medicine March, 2017 SOM Authorship Guidelines, Recent Updates to the ICMJE Uniform Requirements for Scholarship, and the Emerging Role of Social Media in Monitoring Scholarship Kathy O Kane Kreutzer, M.Ed., Office of Faculty

More information

Scientific journal editor core competencies

Scientific journal editor core competencies Scientific journal editor core competencies My disclosures Founding editor-in-chief, Systematic Reviews On the editorial board of several biomedical journals BMC Medicine Advisory member International

More information

Public release of clinical information in drug submissions and medical device applications

Public release of clinical information in drug submissions and medical device applications Public release of clinical information in drug submissions and medical device applications Health Products and Food Branch March 10, 2017 Health Canada is the federal department responsible for helping

More information

Thrombosis and Haemostasis Author Instructions

Thrombosis and Haemostasis Author Instructions Thrombosis and Haemostasis Author Instructions Thank you for contributing to Thrombosis and Haemostasis. Please read the instructions carefully and observe all the directions given. Failure to do so may

More information

11. Type of Research * Type of research maybe: 1. Biomedical research: research conducted primarily in lab setting

11. Type of Research * Type of research maybe: 1. Biomedical research: research conducted primarily in lab setting Definition of Data elements required for submission to NMRR * Indicates data is required for submission # Fields * Definition Title, Identification and Study organization 1. Research Title * Research official

More information

Editor-in-Chief, 23rd March 2017

Editor-in-Chief, 23rd March 2017 Author s response to reviews Title: Single Use and Conventional Bronchoscopes for Broncho alveolar Lavage (BAL) in research: A comparative study (NCT 02515591) Authors: Seher Raza Zaidi (seher.zaidi@lstmed.ac.uk)

More information

ClinicalTrials.gov Registration Guide

ClinicalTrials.gov Registration Guide ClinicalTrials.gov Registration Guide The Food and Drug Administration Amendments Act (FDAAA), National Institutes of Health (NIH) and International Committee of Medical Journal Editors (ICMJE) require

More information

Re: Docket No. FDA-2014-D-1461: Rare Pediatric Disease Priority Review Vouchers

Re: Docket No. FDA-2014-D-1461: Rare Pediatric Disease Priority Review Vouchers February 13, 2015 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA-2014-D-1461: Rare Pediatric Disease Priority Review

More information

Joint statement on public disclosure of results from clinical trials

Joint statement on public disclosure of results from clinical trials Joint statement on public disclosure of results from clinical trials Signatories on 18 May 2017 European Commission for Horizon 2020 Societal Challenge Health Demographic Change and Wellbeing (joined on

More information

Technical Guidance on Clinical Evaluation of Medical Devices

Technical Guidance on Clinical Evaluation of Medical Devices Annex Technical Guidance on Clinical Evaluation of Medical Devices I. Purpose The clinical evaluation of medical devices is the assessment procedure conducted by registration applicants to validate whether

More information

June 14, To the World Medical Association Secretariat:

June 14, To the World Medical Association Secretariat: June 14, 2013 To the World Medical Association Secretariat: The following are the comments from the Executive Committee of the Latin American and Caribbean Network of Bioethics UNESCO 1 to the draft of

More information

Brazil. Remote Voting Card (RVC) Frequently Asked Questions. Published: February 2, 2018

Brazil. Remote Voting Card (RVC) Frequently Asked Questions. Published: February 2, 2018 Brazil Remote Voting Card (RVC) Frequently Asked Questions Published: February 2, 2018 www.issgovernance.com 2018 ISS Institutional Shareholder Services Table of Contents 1. What is the remote voting card

More information

OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS

OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS D i a g n o s t i c s a n d L a b o r a t o r y T e c h n o l o g y OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS Prequalification of Male Circumcision Devices PQMC_007

More information

Indian Journal of Neurosurgery Author Instructions

Indian Journal of Neurosurgery Author Instructions Indian Journal of Neurosurgery Author Instructions Thank you for contributing to Indian Journal of Neurosurgery. Please read the instructions carefully and observe all the directions given. Failure to

More information

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

1201 Maryland Avenue SW, Suite 900, Washington, DC , 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org December 28, 2010 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,

More information

Clinical Research: A Multifaceted Discipline

Clinical Research: A Multifaceted Discipline Clinical Research: A Multifaceted Discipline Anuradha Kulkarni a, Arun Bhatt b* a Senior Associate - Medical & Regulatory Affairs, Clininvent Research Pvt Ltd, A-302, Everest Chambers, Marol Naka, Andheri

More information

International Federation for Emergency Medicine

International Federation for Emergency Medicine International Federation for Emergency Medicine ACN 145 437 216 LINKS TO USEFUL RESEARCH TRAINING URLs GENERAL ONLINE RESOURCES Free or very low cost online access to the major journals in biomedical and

More information

Hospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee)

Hospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee) Page 1 of 8 Hospital Authority (HA) Guide on Research Ethics (for Study Site & Version Effective Date 2 01/02/2015 Document Number HAHO-CE&TM-HA REC Author HA Head Office Steering Committee on Research

More information

Regulatory and ethical requirements in medical device studies. Finland

Regulatory and ethical requirements in medical device studies. Finland Regulatory and ethical in medical device studies Finland SECTIONS A.Type of research SECTIONS A.Type of research We have differentiated 8 types of research: Medical device alone with CE mark use within

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria Question 1: What laws or regulations apply to an application for conducting a clinical

More information

Technical Guidance on Clinical Evaluation of Medical Devices 1

Technical Guidance on Clinical Evaluation of Medical Devices 1 Technical Guidance on Clinical Evaluation of Medical Devices 1 I. Purpose The clinical evaluation of medical devices is the assessment procedure conducted by registration applicants to validate whether

More information

Authorship. KHALED ALSAKKAF, PhD. Dept. of Community Medicine Faculty of Medicine and Health Sciences University of Aden

Authorship. KHALED ALSAKKAF, PhD. Dept. of Community Medicine Faculty of Medicine and Health Sciences University of Aden Authorship KHALED ALSAKKAF, PhD Dept. of Community Medicine Faculty of Medicine and Health Sciences University of Aden The Author s Seven Deadly Sins Sin Examples 1 Carelessness Citation bias, understatement,

More information

Day to day operational activities

Day to day operational activities DEVELOPING AN OPERATIONAL PLAN FOR THE JOURNAL Day to day operational activities Manage editorial matters Perform production Ensure Impact (Visibility & Marketing) Distribute articles/journal Preserve

More information

How is trial registration affecting gjournals?

How is trial registration affecting gjournals? How is trial registration affecting gjournals? Dr Trish Groves Deputy editor, BMJ & Editor in chief, BMJ Open My competing interests Roles at BMJ contributing to, publicising, and leading implementation

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 9 October 2017 EMA/813938/2011 Rev 3* Guideline on good pharmacovigilance practices (GVP) Module VIII Post-authorisation safety studies (Rev 3) Date for coming into effect of first version 2 July 2012

More information

EMEA Speaker Brief Page 1

EMEA Speaker Brief Page 1 EMEA SPEAKER BRIEF Commitment to ethics and integrity Bristol-Myers Squibb (BMS) is committed to the highest standards of ethics and integrity and recognises the high expectations of honesty and transparency

More information

AAD ADVERTISING STANDARDS

AAD ADVERTISING STANDARDS Approved: Board of Directors 11/14/09 AAD ADVERTISING STANDARDS The American Academy of Dermatology and AAD Association (collectively, the Academy ) seeks to advance the science and art of dermatology

More information

RFQ ATTACHMENT V: RESPONSE TEMPLATE

RFQ ATTACHMENT V: RESPONSE TEMPLATE Instructions are provided in blue and may be deleted. Please complete your response in the template provided, and indicate clearly where separate documents are provided. Executive Summary 1. Applicant

More information

Consultancy contract. Request for written proposal. Request to submit a written proposal for a work assignment with UNESCO

Consultancy contract. Request for written proposal. Request to submit a written proposal for a work assignment with UNESCO Consultancy contract Request for written proposal Reference: GEM REPORT 2017 Editor Date: 27 th of October 2016 New deadline: Friday, 16 December 2016 Request to submit a written proposal for a work assignment

More information

Monash University Procedure. Research Outputs Data Collection Procedures. Research Outputs Data Collection Policy

Monash University Procedure. Research Outputs Data Collection Procedures. Research Outputs Data Collection Policy Procedure Title Parent Policy Date Effective Review Date Procedure Owner Category Research Outputs Data Collection Procedures Research Outputs Data Collection Policy 05-June-2013 05-June-2016 Academic

More information

National Health Surveillance Agency. Public Consultation No. 255, dated June 19, 2017 D.O.U of 06/20/2017

National Health Surveillance Agency.  Public Consultation No. 255, dated June 19, 2017 D.O.U of 06/20/2017 National Health Surveillance Agency www.anvisa.gov.br Public Consultation No. 255, dated June 19, 2017 D.O.U of 06/20/2017 The Board of the National Health Surveillance Agency, in the use of the powers

More information

Journal of Clinical Urology (JCU): Declaration Guidelines for Authors

Journal of Clinical Urology (JCU): Declaration Guidelines for Authors Table of Contents 1. Case Report or Case Series... 2 Required Declarations... 2 Example of a completed declarations section:... 2 Example of text that should be used if any declaration is not relevant

More information

April 13, Background

April 13, Background Pfizer Inc 235 East 42nd Street New York, NY 10017-5755 Tel 212 733 4210 Fax 646 383 9249 Email: marc.wilenzick@pfizer.com April 13, 2009 http://www.regulations.gov Christine Ireland Committee management

More information

1.4 Applicable Regulatory Requirement(s) Any law(s) and regulation(s) addressing the conduct of clinical trials of investigational products.

1.4 Applicable Regulatory Requirement(s) Any law(s) and regulation(s) addressing the conduct of clinical trials of investigational products. 1.1 Adverse Drug Reaction (ADR) In the pre-approval clinical experience with a new medicinal product or its new usages, particularly as the therapeutic dose(s) may not be established: all noxious and unintended

More information

DATA SHARING AGREEMENT

DATA SHARING AGREEMENT DATA SHARING AGREEMENT Effective Date: This Data Sharing Agreement ( Agreement ) is effective as of the Effective Date between EMD Serono, One Technology Place, Rockland, MA 02370 and Name ( Institution

More information

Clinical Trials application process, legislation & guidelines

Clinical Trials application process, legislation & guidelines Clinical Trials application process, legislation & guidelines IMB Clinical Trials Seminar 19 th June 2012 Elaine Breslin MB BCh (NUI), PhD, FRCPI Clinical Assessment Manager 19/06/2012 Slide 1 IMB Mission

More information

Seminars in Respiratory and Critical Care Medicine Author Instructions

Seminars in Respiratory and Critical Care Medicine Author Instructions Seminars in Respiratory and Critical Care Medicine Author Instructions Thank you for contributing to Seminars in Respiratory and Critical Care Medicine. Please read the instructions carefully and observe

More information

A notice on the issuance of drug clinical trials, ethical review of the guiding principles

A notice on the issuance of drug clinical trials, ethical review of the guiding principles 药物临床试验伦理审查工作指导原侧.doc 的翻译 A notice on the issuance of drug clinical trials, ethical review of the guiding principles State Food and Drug Administration Note [2010] No. 436 November 2, 2010 Release A notice

More information

Review of Biomedical Image Processing

Review of Biomedical Image Processing BOOK REVIEW Open Access Review of Biomedical Image Processing Edward J Ciaccio Correspondence: ciaccio@columbia. edu Department of Medicine, Columbia University, New York, USA Abstract This article is

More information

Author Statements and Copyright Assignment

Author Statements and Copyright Assignment Author Statements and Copyright Assignment Manuscript title: Corresponding Author: Before your manuscript (the Work ) can be considered for publication in FPM, each author must attest to his or her authorship

More information

Call for tender for translation services for the Translation Centre Frequently asked questions (FAQs) FL/LEG17

Call for tender for translation services for the Translation Centre Frequently asked questions (FAQs) FL/LEG17 Call for tender for translation services for the Translation Centre Frequently asked questions (FAQs) FL/LEG17 Question no. 1: Could you send us the relevant documents for call for tenders FL/LEG17? Answer

More information

07/30/2013. Record of Revisions IRB Page 1 of 17

07/30/2013. Record of Revisions IRB Page 1 of 17 Current Protocol Version 7.1 (Continuing Review) Approved July 30, 2013 Version 7.1 (Amendment) September 6, 2012 Version 7.0 (Continuing Review) July 30, 2012 Version 6.0 (Continuing Review) July 30,

More information

Neuropediatrics Author Instructions

Neuropediatrics Author Instructions Neuropediatrics Author Instructions Thank you for contributing to Neuropediatrics. Please read the instructions carefully and observe all the directions given. Failure to do so may result in unnecessary

More information

SECOND LEVEL DOMAINS

SECOND LEVEL DOMAINS 1 Ref: 2LD Version: 2.6 Title: Second Level Domains Date Issued: 28 April 2014 Status: REPLACED BY PR and OP This policy is issued by Domain Name Commission Limited (DNC or Domain Name Commission) on behalf

More information

DEFINING BEST PRACTICE FOR ADVERSE EVENT REPORTING WITH INDUSTRY-SPONSORED CLINICAL TRIAL MANUSCRIPTS

DEFINING BEST PRACTICE FOR ADVERSE EVENT REPORTING WITH INDUSTRY-SPONSORED CLINICAL TRIAL MANUSCRIPTS 11TH ANNUAL MEETING OF ISMPP DEFINING BEST PRACTICE FOR ADVERSE EVENT REPORTING WITH INDUSTRY-SPONSORED CLINICAL TRIAL MANUSCRIPTS April 28, 2015 Hyatt Regency Crystal City Arlington, VA, USA 11TH ANNUAL

More information

Journal of Academic Ophthalmology Author Instructions

Journal of Academic Ophthalmology Author Instructions Journal of Academic Ophthalmology Author Instructions Thank you for contributing to Journal of Academic Ophthalmology. Please read the instructions carefully and observe all the directions given. Failure

More information

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines 1. Introduction The Canadian Cancer Clinical Trials Network (3CTN) will support a portfolio of academic clinical trials

More information

CUSTOMER SUPPORT SERVICES POLICIES FOR ONLINE SERVICES

CUSTOMER SUPPORT SERVICES POLICIES FOR ONLINE SERVICES FOR DASSASYSTEMES ONLINE CUSTOMER SUPPORT SERVICES POLICIES FOR ONLINE SERVICES 1. At a Glance These Support Policies describe the Support Services applicable to Online Services ordered by Customer pursuant

More information

Quality Assurance in Clinical Trials

Quality Assurance in Clinical Trials Quality Assurance in Clinical Trials Doctor Catherine CORNU, Lyon clinical Investigation Centre EUDIPHARM December 5th, 2011 1 Introduction: quality in clinical research in human subjects Regulatory requirements:

More information

Expand your marketing program with publications specifically for Virginia dentists. MEDIA KIT

Expand your marketing program with publications specifically for Virginia dentists. MEDIA KIT Marketing Opportunities Expand your marketing program with publications specifically for Virginia dentists. Rates MEDIA KIT Closing Dates Specifications VDA ADVERTISING STANDARDS Overview - The Virginia

More information

Guide for Advisors, Jurors and Assessors

Guide for Advisors, Jurors and Assessors Guide for Advisors, Jurors and Assessors Welcome to the BC Arts Council. Peer Assessment is at the core of our grant programs we can t do it without you! You re about to spend a significant amount of time

More information

Journal of Reconstructive Microsurgery Open Author Instructions

Journal of Reconstructive Microsurgery Open Author Instructions Journal of Reconstructive Microsurgery Open Author Instructions Thank you for contributing to Journal of Reconstructive Microsurgery Open. Please read the instructions carefully and observe all the directions

More information

Journal of Clinical Interventional Radiology. Author Instructions

Journal of Clinical Interventional Radiology. Author Instructions Journal of Clinical Interventional Radiology Author Instructions Thank you for contributing to the Journal of Clinical Interventional Radiology. Please read the instructions carefully and observe all the

More information

NIH Policy on the Dissemination of NIH-Funded Clinical Trial Information

NIH Policy on the Dissemination of NIH-Funded Clinical Trial Information This document is scheduled to be published in the Federal Register on 09/21/2016 and available online at https://federalregister.gov/d/2016-22379, and on FDsys.gov [BILLING CODE 4140-01-P] DEPARTMENT OF

More information

FSC PROCEDURE. The Development and Approval of Controlled Wood National Risk Assessments. Forest Stewardship Council FSC-PRO V3-0 D1-0 EN

FSC PROCEDURE. The Development and Approval of Controlled Wood National Risk Assessments. Forest Stewardship Council FSC-PRO V3-0 D1-0 EN Forest Stewardship Council FSC PROCEDURE The Development and Approval of Controlled Wood National Risk Assessments FSC-PRO-60-002 V3-0 D1-0 EN FSC NETWORK Title: Document reference code: Scope: Approval:

More information

II. Funding of Guideline Development Direct funding of evidence-based guideline production by medical and pharmaceutical industry is prohibited.

II. Funding of Guideline Development Direct funding of evidence-based guideline production by medical and pharmaceutical industry is prohibited. EVIDENCE-BASED CLINICAL PRACTICE GUIDELINES Approved: Board of Directors 10/4/97 Revised: Board of Directors 12/10/00 Revised: Board of Directors 11/23/02 Revised: Board of Directors 2/19/05 Revised: Board

More information

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL STUDY PROTOCOL CHAPTER 14 REVISED: OCTOBER 2015

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL STUDY PROTOCOL CHAPTER 14 REVISED: OCTOBER 2015 THE STUDY PROTOCOL The study protocol is a written document detailing how a clinical trial is conducted. The elements of a protocol include: 1. Trial design and organization; 2. Study objectives; 3. Background

More information

Office for Human Subject Protection. University of Rochester

Office for Human Subject Protection. University of Rochester POLICY 1. Purpose Outline the responsibilities and regulatory requirements when conducting human subject research that involves the use of drugs, agents, biological products, or nutritional products (e.g.,

More information

Aflibercept (Eylea) Benefit assessment according to 35a Social Code Book V 1

Aflibercept (Eylea) Benefit assessment according to 35a Social Code Book V 1 IQWiG Reports Commission No. A12-19 Aflibercept (Eylea) Benefit assessment according to 35a Social Code Book V 1 Extract 1 Translation of Sections 2.1 to 2.6 of the dossier assessment Aflibercept (Eylea)

More information

Myeloma UK Policy Working with the Pharmaceutical Industry

Myeloma UK Policy Working with the Pharmaceutical Industry Policy Working with the Pharmaceutical Industry Background The relationship between patient organisations and the pharmaceutical industry has come under increasing scrutiny in recent times, with the media

More information

IMDRF. Final Document. Regulatory Authority Assessor Competence and Training Requirements. IMDRF MDSAP Work Group

IMDRF. Final Document. Regulatory Authority Assessor Competence and Training Requirements. IMDRF MDSAP Work Group IMDRF/ WG /N6 FINAL:2013 IMDRF International Medical Device Regulators Forum Final Document Title: Authoring Group: Regulatory Authority Assessor Competence and Training Requirements IMDRF MDSAP Work Group

More information

General Guidelines. In this sense, contribution of distinct individuals to the outcome of scientific analysis needs to be properly acknowledged.

General Guidelines. In this sense, contribution of distinct individuals to the outcome of scientific analysis needs to be properly acknowledged. PUBLICATIONS GUIDELINES FOR RETROSPECTIVE STUDIES, NON-INTERVENTIONAL PROSPECTIVE TRIALS, AND PROSPECTIVE CLINICAL TRIALS OF THE EUROPEAN GROUP FOR BLOOD AND BONE MARROW TRANSPLANTATION. VERSION JUNE/2012

More information

Bayer Corporate Policy: Global Publications Deriving from Clinical Studies in Humans

Bayer Corporate Policy: Global Publications Deriving from Clinical Studies in Humans Bayer Corporate Policy: Global Publications Deriving from Clinical Studies in Humans Overview The key aspects of this Global Publication Policy are commitment to publish; consistent application of authorship

More information

Designation and notification of conformity assessment bodies 1

Designation and notification of conformity assessment bodies 1 NBOG s Best Practice Guide applicable for MDR, and IVDR 2017-1 Designation and notification of conformity assessment bodies 1 1 Introduction and scope This document aims to provide guidance to the authorities

More information

INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience

INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience Umberto Filibeck Former Head of AIFA GCP Inspectorate and GCP Promotion Unit UNICRI Consultant for Projects on GCP of CTs in developing

More information

How did it evolve? o Public disasters, serious fraud and abuse of human rights. o Trials of War criminals-nuremberg code 1949

How did it evolve? o Public disasters, serious fraud and abuse of human rights. o Trials of War criminals-nuremberg code 1949 ICH GCP Overview What is ICH? ICH is a joint initiative involving both the regulators and the industry as equal partners in the scientific and technical discussions of the testing procedures which are

More information

TEMPORARY JOB OPENING ANNOUNCEMENT

TEMPORARY JOB OPENING ANNOUNCEMENT UNITED NATIONS NATIONS UNIES Ref. No.: TJO-GSC-16-17 (035) TEMPORARY JOB OPENING ANNOUNCEMENT GS-6 TJO Grade Level 1 Programme Management Assistant Functional Title Central Service/Executive Support Cell

More information

3. Human Biomedical Research. Defining Human Biomedical Research

3. Human Biomedical Research. Defining Human Biomedical Research PART B: SECTION III: HUMAN BIOMEDICAL RESEARCH HUMAN BIOMEDICAL RESEARCH 3. Human Biomedical Research Defining Human Biomedical Research 3.1. In this section, we consider what kinds of human biomedical

More information

MARKEY CANCER CENTER CLINICAL RESEARCH ORGANIZATION STANDARD OPERATING PROCEDURES SOP No.: MCCCRO-P

MARKEY CANCER CENTER CLINICAL RESEARCH ORGANIZATION STANDARD OPERATING PROCEDURES SOP No.: MCCCRO-P Page 1 of 5 MARKEY CANCER CENTER CLINICAL RESEARCH ORGANIZATION STANDARD OPERATING PROCEDURES SOP No.: Title: Protocol Review and Monitoring Committee Revision: N/A Revision Date: N/A Functional and Administrative

More information

Impact evaluation proposal form

Impact evaluation proposal form Impact evaluation proposal form BASIC DETAILS Number of the grant submission (to be filled by 3ie) Title of proposed impact evaluation study (Please include intervention type, country and possible method

More information

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE CANCER CENTER SCIENTIFIC REVIEW COMMITTEE The Clinical Scientific Review Committee (SRC) at The Medical College of Wisconsin Cancer Center plays a vital role in protocol review and monitoring to ensure

More information

REGULATORY REQUIREMENTS FOR CLINICAL TRIAL APPROVAL MEDICAL DEVICES DR D DIALE MRS P NKAMBULE. 02 December 2015

REGULATORY REQUIREMENTS FOR CLINICAL TRIAL APPROVAL MEDICAL DEVICES DR D DIALE MRS P NKAMBULE. 02 December 2015 REGULATORY REQUIREMENTS FOR CLINICAL TRIAL APPROVAL MEDICAL DEVICES DR D DIALE MRS P NKAMBULE 02 December 2015 LAYOUT Background to clinical trials Stakeholders in clinical trials Legislative requirements

More information

POLICY ON MANAGING POLICIES, PROCEDURES AND GUIDANCE DOCUMENTS

POLICY ON MANAGING POLICIES, PROCEDURES AND GUIDANCE DOCUMENTS POLICY ON MANAGING POLICIES, PROCEDURES AND GUIDANCE DOCUMENTS Version: 6 Date Ratified: February 2017 Review Date: February 2020 Applies to: Senior Managers and staff who produce procedural documents.

More information

Understanding clinical research trials

Understanding clinical research trials Understanding clinical research trials Dr. Isabelle Fleury Medical Hemato-oncologist Hôpital Maisonneuve-Rosemont CIUSSS de l Est-de-l Île-de-Montréal Goals of this presentation Better understand clinical

More information

Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form

Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form A. Demographic Information Date of Submission: Reason for Submission: New Project Response to Comments Reconsideration Disapproval

More information

Manual for Submission of Drug Clinical Development Dossier (DCDD) and Clinical Trial Specific Dossier v.1

Manual for Submission of Drug Clinical Development Dossier (DCDD) and Clinical Trial Specific Dossier v.1 Manual for Submission of Drug Clinical Development Dossier (DCDD) and Clinical Trial Specific Dossier v.1 Brasília, 2015 Copyright 2015. Brazilian Health Surveillance Agency. Partial or complete reproduction

More information

COMMUNITY PRIORITY EVALUATION PANEL AND ITS PROCESSES

COMMUNITY PRIORITY EVALUATION PANEL AND ITS PROCESSES COMMUNITY PRIORITY EVALUATION PANEL AND ITS PROCESSES Overview At the time of submitting the new gtld application, applicants had the opportunity to designate themselves as a community-based application,

More information

September 12, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

September 12, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 September 12, 2013 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: : Draft Guidance for Industry on Pediatric Study Plans: Content

More information

Regulatory and ethical requirements in medical devices studies. France

Regulatory and ethical requirements in medical devices studies. France Regulatory and ethical in medical devices studies France SECTIONS A.Type of research SECTIONS A.Type of research We have differentiated 8 types of research: Medical device alone with CE mark use within

More information

Standards of proficiency. Biomedical scientists

Standards of proficiency. Biomedical scientists Standards of proficiency Biomedical scientists Contents Foreword 1 Introduction 3 Standards of proficiency 7 Foreword We are pleased to present the Health and Care Professions Council s standards of proficiency

More information

EFPIA-PHRMA PRINCIPLES FOR RESPONSIBLE CLINICAL TRIAL DATA SHARING REPORT ON THE 2016 MEMBER COMPANY SURVEY

EFPIA-PHRMA PRINCIPLES FOR RESPONSIBLE CLINICAL TRIAL DATA SHARING REPORT ON THE 2016 MEMBER COMPANY SURVEY EFPIA-PHRMA PRINCIPLES FOR RESPONSIBLE CLINICAL TRIAL DATA SHARING REPORT ON THE 2016 MEMBER COMPANY SURVEY PREAMBLE The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the

More information

3.1. Overall Principal Investigator (PI), who holds the IND and is the Sponsor.

3.1. Overall Principal Investigator (PI), who holds the IND and is the Sponsor. SOP #: RCO-100 Page: 1 of 11 1. POLICY STATEMENT: An Overall Principal Investigator (PI) who holds an Investigational New Drug Application (IND) and who is the Sponsor of the research has additional responsibilities

More information

MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155

MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 EXECUTIVE SUMMARY Medical device regulations around the world generally require manufacturers of most types of medical devices to supply data as part

More information

Good Clinical Practice

Good Clinical Practice Dublin Academic Medical Centre Good Clinical Practice Patrick Murray, MD, FASN, FRCPI Professor, University College Dublin, Mater Misericordiae University Hospital, Dublin, Ireland patrick.murray@ucd.ie

More information

Guidelines for Social Media Engagement. for the Consumer Health Product Industry VOLUNTARY GUIDE

Guidelines for Social Media Engagement. for the Consumer Health Product Industry VOLUNTARY GUIDE Guidelines for Social Media Engagement for the Consumer Health Product Industry VOLUNTARY GUIDE March 2016 Table of Contents 1.0 Background. 3 1.1 Objective.. 3 1.2 Guiding Principles.. 4 2.0 Scope.. 4

More information

Critical Reviews in Biotechnology Instructions for Authors

Critical Reviews in Biotechnology Instructions for Authors About the Journal Aims and Scope Editors-in-Chief Manuscript Submission Critical Reviews in Biotechnology Instructions for Authors Manuscript Preparation File preparation and types Title Page Abstract

More information

G4 DEVELOPMENT. Document 2 of 12 Statistics: Quantitative Online Feedback. Second G4 Public Comment Period: Submissions.

G4 DEVELOPMENT. Document 2 of 12 Statistics: Quantitative Online Feedback. Second G4 Public Comment Period: Submissions. G4 DEVELOPMENT Document 2 of 12 Statistics: Quantitative Online Feedback February 2013 INTRODUCTION ABOUT THE SUBMISSIONS DOCUMENTS In 2010 GRI began the development of the fourth generation of its Sustainability

More information

Positive Behavior Support Facilitator Portfolio Standard Process Application Contents of Portfolio Packet

Positive Behavior Support Facilitator Portfolio Standard Process Application Contents of Portfolio Packet Positive Behavior Support Facilitator Portfolio Standard Process Application Contents of Portfolio Packet Cover Sheet Summary of Requirements Checklist of Portfolio Contents Résumé or Abbreviated Vitae

More information

LABORATORY TRAINING LOGBOOK

LABORATORY TRAINING LOGBOOK REGISTRATION TRAINING PORTFOLIO FOR THE IBMS CERTIFICATE OF COMPETENCE LABORATORY TRAINING LOGBOOK Version 4.1 www.ibms.org Trainee record details Registration Training Portfolio Case No: Surname: First

More information

Sunshine on Europe: impact of recent EFPIA and EU guidelines on publication planners. Susan Scott, PhD, CMPP Director, Scott Pharma Solutions Ltd

Sunshine on Europe: impact of recent EFPIA and EU guidelines on publication planners. Susan Scott, PhD, CMPP Director, Scott Pharma Solutions Ltd Sunshine on Europe: impact of recent EFPIA and EU guidelines on publication planners Susan Scott, PhD, CMPP Director, Scott Pharma Solutions Ltd Disclaimer As an independent consultant, the views expressed

More information

Journal of Pediatric Genetics Author Instructions

Journal of Pediatric Genetics Author Instructions Journal of Pediatric Genetics Author Instructions Thank you for contributing to Journal of Pediatric Genetics. Please read the instructions carefully and observe all the directions given. Failure to do

More information

EXECUTIVE DIRECTOR OF THE EUROPEAN CHEMICALS AGENCY (ECHA) HELSINKI

EXECUTIVE DIRECTOR OF THE EUROPEAN CHEMICALS AGENCY (ECHA) HELSINKI EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL VACANCY NOTICE EXECUTIVE DIRECTOR OF THE EUROPEAN CHEMICALS AGENCY (ECHA) HELSINKI General description of tasks and role of the Agency The

More information

INSTRUCTION TO AUTHORS

INSTRUCTION TO AUTHORS Journal of Thoracic Disease pissn: 2072-1439 eissn: 2077-6624 INSTRUCTION TO AUTHORS The Journal of Thoracic Disease (JTD, J Thorac Dis, pissn: 2072-1439; eissn: 2077-6624) was founded in Dec 2009, and

More information

HOSPITAL AUTHORITY (HA) GUIDE

HOSPITAL AUTHORITY (HA) GUIDE Page 1 of 14 HOSPITAL AUTHORITY (HA) GUIDE ON RESEARCH ETHICS (for Study Site & Research Ethics Committee) Revision Number: 1 (The document supersedes HA RE001 Hospital Authority Guide for Cluster Research

More information